TB Education, Training and Resources
Training Materials
| Document Number | Title | Revision Date |
|---|---|---|
| TB-905 | TB Skin Test Competency Checklist | 8/2017 |
| 13-14599 | Venipuncture Performance Evaluation | 4/2015 |
Brown Bag
| Title | Revision Date |
|---|---|
| Drug-Resistant TB in Texas - Tools for Success | 4/2023 |
| Therapeutic Drug Monitoring: A Tool for Case Management | 12/2018 |
| TB Public Health Follow-Up Tools and Case Studies | 8/2018 |
| Tuberculosis Targeted Testing | 6/2018 |
| Outpatient Case Management of Drug-Resistant TB | 4/2018 |
| TB GIMS | 2/2018 |
Fact Sheets
| Document Number | Title | Revision Date |
|---|---|---|
| What Tuberculosis Clinicians Should Know About Nitrosamines | 4/2022 | |
| TB-915 | Take on TB | 10/2020 |
| 1 2 3s of TB | 3/2020 | |
| 13-13692 | TB in Texas | 4/2020 |
| 13-15777 | Tuberculosis Along the Texas-Mexico Border | 1/2021 |
| TB-416 | Tuberculosis Among Texans Experiencing Homelessness (English) | 10/2018 |
| TB-416a | Tuberculosis Among Texans Experiencing Homelessness (Spanish) | 10/2018 |
CDC Resource Documents
TB Guidelines – From CDC Division of TB Elimination, a listing of all TB guidelines issued from the division
Recommendations for Use of Isoniazid-Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection – From CDC MMWR Weekly: December 9, 2011; 60 (48); 1650-1653
Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium Tuberculosis Infection - United States, 2010 – From CDC MMWR Recommendations and Reports; June 25, 2010; 59 (RR-05); 1-25
Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis – From CDC MMWR Weekly; January 16, 2009, 58 (01); 7-10
Plan to Combat Extensively Drug-Resistant Tuberculosis – From CDC MMWR Recommendations and Reports; February 13, 2009; 58 (RR-03); 1-43
Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC – From CDC MMWR Recommendations Reports; July 7, 2006; 55 (RR-09); 1-44
Guidelines for Using the QuantiFERON-TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States – From CDC MMWR Recommendations and Reports; December 16, 2005; 54 (No. RR-15); 49-55
Controlling Tuberculosis in the United States - Recommendations from the American Thoracic Society, CDC, and the Infectious Disease Society of America – From CDC MMWR Weekly; November 4, 2005; 54 (RR-12); 1-81
Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005 – From CDC MMWR Recommendations and Reports; December 30, 2005; 54 (RR-17); 1-141
Treatment of Tuberculosis – American Thoracic Society, CDC, and Infectious Diseases Society of America MMWR; June 20, 2003; 52 (RR-11); 1-77
Progressing Toward Tuberculosis Elimination in Low-Incidence Areas of the United States: Recommendations of the Advisory Council for the Elimination of Tuberculosis – From CDC MMWR Recommendations and Reports; May 3, 2002; 51 (RR-05); 1- 16
Tuberculosis Technical Instruction for Panel Physicians